Was the RMTI CEO’s 30,000-share grant an open-market stock purchase?

No, the 30,000-share transaction was a grant recorded at $0.00 per share, not an open-market purchase. It reflects a compensation-related award of restricted stock units rather than the CEO buying shares on the public market.

[Form 4] ROCKWELL MEDICAL, INC. Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Strobeck Mark reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. reported that President and CEO Mark Strobeck received an award of 30,000 shares of Common Stock as a grant, recorded at a price of $0.00 per share. Following this award, he directly beneficially owns 62,349 shares.

Footnotes explain that the award consists of restricted stock units that vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to his continued service. The company also effected a 1-for-10 reverse stock split effective at 12:01 AM on July 1, 2026, which reduced the number of shares held and proportionately adjusted outstanding equity awards, with post-transaction holdings already reflecting this split.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Strobeck Mark

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,000	$0.00	--

Holdings After Transaction: Common Stock — 62,349 shares (Direct)

Footnotes (1)

Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Key Figures

RSU grant size: 30,000 shares Grant price: $0.00 per share Shares owned after transaction: 62,349 shares +2 more

5 metrics

RSU grant size 30,000 shares Restricted stock units granted to CEO on July 1, 2026

Grant price $0.00 per share Recorded price for the 30,000-share RSU award

Shares owned after transaction 62,349 shares Common Stock beneficially owned directly by CEO after grant and reverse split

Reverse split ratio 1-for-10 Common Stock reverse split effective July 1, 2026

Vesting schedule 3 equal installments RSUs vest on first, second and third anniversaries of July 1, 2026

Key Terms

Restricted stock units ("RSUs"), 1-for-10 reverse split, Amount of Securities Beneficially Owned Following Reported Transaction(s), equity awards

4 terms

Restricted stock units ("RSUs") financial

"Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

1-for-10 reverse split financial

"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction..."

Amount of Securities Beneficially Owned Following Reported Transaction(s) regulatory

"Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s)..."

equity awards financial

"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."

Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 09:21 AM Accepted by SEC EDGAR 07/06/2026 - 09:21 AM

FAQ

What insider transaction did RMTI CEO Mark Strobeck report?

Mark Strobeck reported an acquisition of 30,000 shares of Rockwell Medical Common Stock as a grant. The award was recorded at $0.00 per share and represents compensation in the form of restricted stock units rather than an open-market purchase.

How many Rockwell Medical (RMTI) shares does the CEO hold after this Form 4?

After the reported transaction, President and CEO Mark Strobeck directly beneficially owns 62,349 shares of Rockwell Medical Common Stock. This figure already reflects the impact of the company’s 1-for-10 reverse stock split effective July 1, 2026.

How do the 30,000 RSUs for RMTI’s CEO vest over time?

The 30,000 restricted stock units vest in three equal installments on the first, second and third anniversaries of July 1, 2026. Vesting is conditioned on Mark Strobeck’s continued service to Rockwell Medical through each applicable vesting date.

What reverse stock split did Rockwell Medical implement on July 1, 2026?

Effective at 12:01 AM on July 1, 2026, Rockwell Medical implemented a 1-for-10 reverse split of its common stock. This reduced the number of shares held and proportionately adjusted outstanding equity awards, including the CEO’s reported holdings.

How did the reverse split affect the CEO’s reported RMTI holdings?

The 1-for-10 reverse split reduced the number of shares held by Mark Strobeck and adjusted his equity awards proportionately. The 62,349 shares shown as beneficially owned following the transaction are already adjusted to reflect the reverse split.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strobeck Mark

(Last)

(First)

(Middle)

30142 WIXOM ROAD

(Street)

WIXOM

MICHIGAN

48393

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/01/2026		A⁽¹⁾		30,000	A	$0	62,349⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer.

2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Remarks:

	/s/ Megan Timmins, Attorney-in-fact for Mark Strobeck	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR